Dearborn Partners LLC Becton Dickinson & CO Transaction History

Dearborn Partners LLC

$2.42 Billion
Q3 2024

A detailed history of Dearborn Partners LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Dearborn Partners LLC holds 138,959 shares of BDX stock, worth $31.2 Million. This represents 1.39% of its overall portfolio holdings.

Number of Shares

138,959

Previous 141,488 1.79%

Holding current value

$31.2 Million

Previous $33.1 Million 1.32%

% of portfolio

1.39%

Previous 1.45%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$221.47 - $242.41 $560,097 - $613,054	-2,529 Reduced 1.79%	138,959 $33.5 Million
Q2 2024 Jul 26, 2024	SELL	$225.07 - $246.17 $151,472 - $165,672	-673 Reduced 0.47%	141,488 $33.1 Million
Q1 2024 May 08, 2024	SELL	$233.45 - $247.73 $6.56 Million - $6.96 Million	-28,094 Reduced 16.5%	142,161 $35.2 Million
Q4 2023 Jan 26, 2024	SELL	$232.24 - $267.23 $802,621 - $923,546	-3,456 Reduced 1.99%	170,255 $41.5 Million
Q3 2023 Nov 01, 2023	SELL	$254.9 - $283.59 $112,665 - $125,346	-442 Reduced 0.25%	173,711 $44.9 Million
Q2 2023 Aug 03, 2023	BUY	$238.39 - $265.32 $200,724 - $223,399	842 Added 0.49%	174,153 $46 Million
Q1 2023 May 04, 2023	SELL	$229.71 - $259.35 $226,494 - $255,719	-986 Reduced 0.57%	173,311 $42.9 Million
Q4 2022 Feb 02, 2023	SELL	$218.29 - $256.91 $516,255 - $607,592	-2,365 Reduced 1.34%	174,297 $44.3 Million
Q3 2022 Oct 25, 2022	SELL	$51.03 - $264.23 $4,490 - $23,252	-88 Reduced 0.05%	176,662 $39.4 Million
Q2 2022 Jul 20, 2022	BUY	$234.74 - $275.42 $1,408 - $1,652	6 Added 0.0%	176,750 $43.6 Million
Q1 2022 May 04, 2022	BUY	$243.64 - $270.48 $31,673 - $35,162	130 Added 0.07%	176,744 $47 Million
Q4 2021 Jan 28, 2022	BUY	$230.08 - $250.94 $52,458 - $57,214	228 Added 0.13%	176,614 $44.4 Million
Q3 2021 Oct 27, 2021	SELL	$232.72 - $256.47 $2.06 Million - $2.27 Million	-8,848 Reduced 4.78%	176,386 $43.4 Million
Q2 2021 Jul 26, 2021	BUY	$232.65 - $254.58 $138,194 - $151,220	594 Added 0.32%	185,234 $45 Million
Q1 2021 Apr 29, 2021	BUY	$232.09 - $256.88 $307,519 - $340,366	1,325 Added 0.72%	184,640 $44.9 Million
Q4 2020 Jan 27, 2021	BUY	$221.92 - $245.94 $220,144 - $243,972	992 Added 0.54%	183,315 $45.9 Million
Q3 2020 Oct 20, 2020	SELL	$215.77 - $276.76 $54,805 - $70,297	-254 Reduced 0.14%	182,323 $42.4 Million
Q2 2020 Jul 30, 2020	SELL	$219.9 - $263.41 $1.61 Million - $1.93 Million	-7,324 Reduced 3.86%	182,577 $43.7 Million
Q1 2020 May 11, 2020	BUY	$195.69 - $279.01 $75,144 - $107,139	384 Added 0.2%	189,901 $43.6 Million
Q4 2019 Jan 28, 2020	BUY	$236.45 - $266.82 $1.76 Million - $1.98 Million	7,439 Added 4.09%	189,517 $51.5 Million
Q3 2019 Oct 29, 2019	BUY	$230.58 - $256.08 $228,043 - $253,263	989 Added 0.55%	182,078 $46.1 Million
Q2 2019 Jul 29, 2019	BUY	$217.4 - $246.08 $658,722 - $745,622	3,030 Added 1.7%	181,089 $45.6 Million
Q1 2019 May 01, 2019	BUY	$206.05 - $248.17 $394,791 - $475,493	1,916 Added 1.09%	178,059 $44.5 Million
Q4 2018 Feb 04, 2019	BUY	$204.73 - $257.93 $107,687 - $135,671	526 Added 0.3%	176,143 $39.7 Million
Q3 2018 Oct 24, 2018	BUY	$233.07 - $256.0 $316,275 - $347,392	1,357 Added 0.78%	175,617 $45.8 Million
Q2 2018 Aug 14, 2018	SELL	$208.1 - $233.85 $953,306 - $1.07 Million	-4,581 Reduced 2.56%	174,260 $41.7 Million
Q1 2018 May 01, 2018	SELL	$205.46 - $240.27 $1.1 Million - $1.28 Million	-5,345 Reduced 2.9%	178,841 $38.8 Million
Q4 2017 Feb 02, 2018	BUY	$189.0 - $222.64 $568,512 - $669,701	3,008 Added 1.66%	184,186 $39.4 Million
Q3 2017 Nov 13, 2017	SELL	$186.89 - $198.9 $1.24 Million - $1.32 Million	-6,632 Reduced 3.53%	181,178 $35.5 Million
Q2 2017 Aug 09, 2017	BUY	N/A	187,810	187,810 $36.6 Million

Others Institutions Holding BDX

# of Institutions

1,737

Shares Held

250M

Call Options Held

690K

Put Options Held

787K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $64B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dearborn Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dearborn Partners LLC with notifications on news.

Account

Dearborn Partners LLC Becton Dickinson & CO Transaction History